Differentiated embryonic chondrocyte-expressed gene 1 promotes temozolomide resistance by modulating the SP1-MGMT axis in glioblastoma.
Year: 2021
Type: article
Abstract: expression has a predictive value for TMZ resistance and poor outcome in glioma patients, and is a novel therapeutic target in TMZ-resistant glioma.
Source: PubMed
Authors: Weifeng Lv, Qi Li, Bo Jia, Yalong He, Yi Ru, Qingdong Guo, Xia Li, Wei Lin
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3162495221